CD81

CD81 — Cluster of Differentiation 81

Pathway Diagram

```mermaid
flowchart TD
CD8["CD8<br/>T Cell Receptor"]

CD8 -->|"activates"| TCellActivation["T Cell<br/>Activation"]
CD8 -->|"expressed_in"| Neuroinflammation["Neuroinflammation"]

TCellActivation -->|"leads_to"| CytotoxicResponse["Cytotoxic<br/>Response"]
TCellActivation -->|"triggers"| CytokineRelease["Cytokine<br/>Release"]

CytotoxicResponse -->|"activates"| MS["Multiple<br/>Sclerosis"]
CytotoxicResponse -->|"damages"| Neurons["Neuronal<br/>Damage"]

CytokineRelease -->|"promotes"| Inflammation["Chronic<br/>Inflammation"]
CytokineRelease -->|"activates"| Microglia["Microglial<br/>Activation"]

Inflammation -->|"contributes_to"| ALS["Amyotrophic Lateral<br/>Sclerosis"]
Inflammation -->|"accelerates"| Aging["Cellular<br/>Aging"]

Microglia -->|"releases"| ProInflammatory["Pro-inflammatory<br/>Mediators"]
Microglia -->|"phagocytosis"| SynapticPruning["Synaptic<br/>Pruning"]

ProInflammatory -->|"damages"| BBB["Blood-Brain<br/>Barrier"]
ProInflammatory -->|"triggers"| Neurodegeneration["Neurodegeneration"]

SynapticPruning -->|"leads_to"| CognitiveDecline["Cognitive<br/>Decline"]

Neurons -->|"death"| Neurodegeneration
BBB -->|"compromise"| Neurodegeneration

Neurodegeneration -->|"manifests_in"| Parkinson["Parkinson's<br/>Disease"]

style CD8 fill:#006494
style MS fill:#ef5350
style ALS fill:#ef5350
style Parkinson fill:#ef5350
style Neurodegeneration fill:#ef5350
style T

CD81 — Cluster of Differentiation 81

Pathway Diagram

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#1a5f7a; color:white; text-align:center; font-size:1.1em;">CD81</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>CD81</td></tr>
<tr><td><strong>Full Name</strong></td><td>CD81 Molecule</td></tr>
<tr><td><strong>Chromosome</strong></td><td>11p15.5</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[975](https://www.ncbi.nlm.nih.gov/gene/975)</td></tr>
<tr><td><strong>OMIM</strong></td><td>[186845](https://omim.org/entry/186845)</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000110601</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P60033](https://www.uniprot.org/uniprot/P60033)</td></tr>
<tr><td><strong>Protein Class</strong></td><td>Tetraspanin</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Hepatitis C, Exosome Biology, Neuroinflammation, Alzheimer's Disease, Parkinson's Disease</td></tr>
</table>
</div>

Overview

The CD81 gene encodes CD81 (Cluster of Differentiation 81), a member of the tetraspanin family of membrane proteins. Tetraspanins are characterized by four transmembrane domains that organize into microdomains called tetraspanin-enriched microdomains (TEMs) or the tetraspanin web. These microdomains serve as platforms for organizing signaling complexes, facilitating membrane fusion events, and coordinating intercellular communication. CD81 is widely expressed in immune cells, epithelial cells, and most notably for neurodegeneration research, in neurons and glial cells of the central nervous system.

CD81 has emerged as a protein of significant interest in neurodegenerative disease research due to its central role in [exosome biology](/entities/exosomes), [neuroinflammation](/mechanisms/neuroinflammation), and cell-cell communication in the brain. Exosomes, a type of extracellular vesicle, have been implicated in the spread of pathological proteins in both [Alzheimer's disease](/diseases/alzheimers-disease) and [Parkinson's disease](/diseases/parkinsons-disease). CD81, as a key exosome biogenesis protein, influences the composition and release of these vesicles, potentially affecting disease progression through mechanisms including the propagation of toxic protein aggregates, modulation of neuroinflammation, and disruption of synaptic function.

Gene and Protein Structure

Genomic Organization

The CD81 gene is located on chromosome 11p15.5, a region that has been conserved across mammalian species. The gene spans approximately 16 kb and consists of 9 exons encoding a 236-amino acid protein with a molecular mass of approximately 26 kDa. The genomic organization reflects the characteristic tetraspanin structure, with conserved exon-intron boundaries corresponding to the protein's distinct functional domains.

Protein Architecture

CD81 possesses the canonical tetraspanin structure that defines this protein family:

The LEL of CD81 is particularly important for its functions, as it contains binding sites for various partner proteins including integrins, MHC molecules, and other tetraspanins. This allows CD81 to act as a molecular organizer, bringing together diverse proteins into functional signaling complexes.

Tetraspanin-Enriched Microdomains

Organization and Composition

CD81 localizes to specialized membrane microdomains known as tetraspanin-enriched microdomains (TEMs) or the tetraspanin web. These are distinct from lipid rafts but may partially overlap with them. Within TEMs, CD81 interacts with other tetraspanins (CD9, CD63, CD151), integrins, signaling receptors, and cytoplasmic signaling molecules.

The formation of TEMs is driven by:

• Palmitoylation: CD81 contains multiple cysteine residues in its transmembrane domains and cytoplasmic loops that undergo palmitoylation, promoting homodimerization and heterodimerization with other tetraspanins
• Hydrophobic matching: The transmembrane domains of tetraspanins have similar lengths, facilitating packing interactions
• Protein-protein interactions: The large extracellular loop mediates specific interactions with partner proteins

Signaling Functions

Within TEMs, CD81 organizes signaling complexes that regulate:

Expression in the Nervous System

Neuronal Expression

CD81 is expressed in neurons throughout the brain, with particular enrichment in specific neuronal populations relevant to neurodegenerative diseases:

• Hippocampal neurons: High expression in CA1 and CA3 pyramidal neurons, the dentate gyrus granule cells, and interneurons. The hippocampus is critically affected in Alzheimer's disease, making CD81 expression in this region particularly relevant.
• Cortical pyramidal neurons: Expressed in both layer 2/3 and layer 5 pyramidal neurons in the cerebral cortex.
• Cerebellar Purkinje cells: These large neurons, which are particularly vulnerable in certain cerebellar ataxias, express CD81 at high levels.
• Dopaminergic neurons: The substantia nigra pars compacta dopaminergic neurons that degenerate in Parkinson's disease express CD81.
• Synaptic terminals: CD81 localizes to both presynaptic and postsynaptic compartments, where it may influence synaptic vesicle dynamics and receptor trafficking.

Glial Expression

In addition to neurons, CD81 is expressed in all major glial cell types:

• Astrocytes: CD81 is expressed in astrocytes throughout the brain, where it may influence astrocyte-neuron communication and response to injury.
• Microglia: The brain's resident immune cells express high levels of CD81. Microglial CD81 is involved in phagocytosis, antigen presentation, and inflammatory responses.
• Oligodendrocytes: CD81 expression in oligodendrocyte lineage cells suggests roles in myelination and white matter biology.

Role in Exosome Biology

Exosome Biogenesis

Exosomes are small extracellular vesicles (30-150 nm diameter) that are generated through the inward budding of late endosomal membranes to form multivesicular bodies (MVBs). When MVBs fuse with the plasma membrane, their internal vesicles are released as exosomes. CD81 is one of the most enriched tetraspanins in exosome membranes and plays critical roles in:

Exosomes in Neurodegeneration

Exosomes have emerged as important vectors in neurodegenerative disease pathogenesis:

Alzheimer's Disease:

• Exosomes can carry amyloid-beta peptides and tau proteins, potentially spreading pathology throughout the brain
• Microglial exosomes may contribute to the inflammatory component of AD
• Exosome-mediated clearance of toxic proteins may be protective, but this function appears impaired in disease

• Exosomes can transport alpha-synuclein between neurons, potentially propagating Lewy body pathology
• Glial exosomes may influence dopaminergic neuron survival
• Exosome release may be altered in PD, affecting intercellular communication in the substantia nigra

• Modulating CD81 function could alter exosome release and composition
• Understanding CD81's role may enable development of exosome-based biomarkers
• Targeting exosome pathways may offer new therapeutic strategies

Role in Neuroinflammation

Tetraspanins and Immune Function

CD81 has well-characterized roles in immune cell function that extend to neuroinflammation in the central nervous system:

T Cell Function:

• CD81 associates with the T cell receptor (TCR) complex
• Modulates TCR signaling strength and T cell activation thresholds
• Influences T cell migration and tissue infiltration

• Essential for B cell development and maturation
• Forms the B cell receptor (BCR) co-receptor complex
• Modulates B cell activation and antibody responses

• CD81 is expressed on antigen-presenting cells
• Modulates MHC class II function and immune synapse formation

Neuroinflammation in Neurodegeneration

Neuroinflammation is a common feature of both Alzheimer's and Parkinson's diseases, characterized by microglial activation, cytokine release, and secondary neuronal damage. CD81 influences neuroinflammation through:

CD81 and Alzheimer's Disease

Evidence for Involvement

Multiple lines of evidence suggest CD81 may play a role in Alzheimer's disease pathogenesis:

Therapeutic Implications

Understanding CD81's role in AD may lead to therapeutic strategies:

• Modulating exosome release to reduce pathogenic protein spread
• Targeting neuroinflammation through CD81 pathways
• Developing biomarkers based on CD81-containing exosomes

CD81 and Parkinson's Disease

Evidence for Involvement

CD81's relevance to Parkinson's disease includes:

Biomarker Potential

CD81-containing exosomes from cerebrospinal fluid or blood may serve as biomarkers:

• Reflect disease state or progression
• Provide insights into disease mechanisms
• Potentially guide therapeutic decisions

CD81 in Other Neurological Conditions

Multiple Sclerosis

CD81 is involved in immune cell function relevant to multiple sclerosis:

• T cell activation and migration
• B cell function and autoantibody production
• Potential for therapeutic targeting

Epilepsy

Emerging evidence suggests CD81 may play roles in epilepsy:

• Altered expression in epileptic tissue
• Potential involvement in inflammatory mechanisms

Brain Tumors

In gliomas and other brain tumors:

• CD81 expression may influence tumor cell migration
• Exosome release may contribute to tumor progression

Neurodevelopmental Disorders

Given CD81's roles in neuronal development:

• Potential involvement in autism spectrum disorders
• May affect synaptic development and function

Protein-Protein Interactions

CD81 interacts with numerous partner proteins relevant to neurodegeneration:

| Partner Protein | Interaction Type | Functional Significance |
|-----------------|------------------|-------------------------|
| CD9 | Tetraspanin-tetraspanin | Exosome formation, membrane organization |
| CD63 | Tetraspanin-tetraspanin | Exosome cargo sorting |
| CD151 | Tetraspanin-tetraspanin | Cell migration, membrane organization |
| Integrins (β1, β2) | Direct binding | Cell adhesion, migration |
| MHC Class II | Direct binding | Antigen presentation |
| PD-1 | Direct binding | Immune checkpoint signaling |
| EGFR | Indirect | Growth factor signaling |
| Clathrin | Indirect | Endocytosis |

Therapeutic Approaches

Small Molecule Modulators

No CD81-targeted drugs exist, but approaches being explored include:

• Antibodies targeting the large extracellular loop
• Peptides that disrupt tetraspanin interactions
• Small molecules affecting tetraspanin organization

Gene Therapy

AAV-mediated approaches to modulate CD81 expression:

• Overexpression to enhance protective functions
• Knockdown to reduce pathogenic exosome release

Exosome-Based Therapies

Understanding CD81's role enables:

• Engineering exosomes for therapeutic delivery
• Targeting exosome pathways to modulate disease

Research Methods

Key approaches for studying CD81 in neurodegeneration:

• Biochemistry: Western blotting, immunoprecipitation to identify interaction networks
• Imaging: Confocal microscopy to localize CD81 in neurons and glia
• Exosome isolation: Differential centrifugation and size-exclusion chromatography
• Proteomics: Mass spectrometry to identify CD81-containing complexes
• Genetics: CRISPR to manipulate CD81 expression in cellular models
• Animal models: Transgenic and knockout mice to assess in vivo function
• Single-cell RNA-seq: Profile CD81 expression across cell types in disease
• Flow cytometry: Analyze exosome surface markers including CD81

Clinical Relevance

Biomarker Potential

CD81-containing exosomes have significant potential as biomarkers:

Therapeutic Targets

CD81-based therapeutic strategies include:

| Strategy | Approach | Status |
|----------|----------|--------|
| Exosome modulation | Reduce pathogenic exosome release | Preclinical |
| Antibody therapy | Block CD81-mediated pathology | Research |
| Gene therapy | Modulate CD81 expression | Early research |
| Small molecules | Target tetraspanin interactions | Research |

Evolutionary Conservation

CD81 shows strong evolutionary conservation:

• Mammals: Highly conserved with >95% identity
• Avians: Functional orthologs identified
• Fish: Conserved tetraspanin structure
• Invertebrates: Related tetraspanins present

See Also

• [Exosomes](/entities/exosomes)
• [Neuroinflammation](/mechanisms/neuroinflammation)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Microglia](/cell-types/microglia-neuroinflammation)
• [Extracellular Vesicles](/mechanisms/extracellular-vesicles)
• [Tetraspanins](/mechanisms/tetraspanins)
• [Protein Aggregation](/mechanisms/protein-aggregation)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving CD81 discovered through SciDEX knowledge graph analysis: